-
Characteristics of the participants.
Abbreviations: SD, standard deviation; BMI, body mass index; WC, waist circumference; WHtR, waist-to-height ratio; HDL-c, high-density lipoprotein cholesterol; LDL-c,... -
Primers used in this study.
a Liu et al., 2011 [19]. b Ji et al., 2007 [20]. c Wei et al., 2010 [21]. d Noteborn et al., 2013 [22]. *Positions correspond to: IBDV (JQ684022), IBV (KJ425500), AEV... -
Patient Characteristics.
Abbreviations: AML, acute myeloid leukemia; sAML, secondary AML; ALL, acute lymphoblastic leukemia; PMF, primary myelofibrosis; CLL: chronic lymphoblastic leukemia; SAA, severe... -
Experimental setup.
Our experimental setup allows a validation of the classifiers on data from the same institution (Intra1 and Intra2), data from the same and another institution (Cross1 and... -
Bacterial strains and plasmids.
aProvided by Jon Beckwith.bIn the experiment with HU (Figure 2, Table 2) the LJ52 strain was used. It is referred to as MG1655 for simplicity.cObtained from The Coli Genetic... -
Data collection and refinement statistics.
1Statistics for data from the highest-resolution shell are shown in parentheses. 2 R sym =(ΣΣ|Ihkl−〈I〉|)/(ΣIhkl), where the average intensity <I> is taken... -
Participant Demographics.
1Age at enrolment,2mean value (range),3Body Mass Index,4Pre-enrolment IgA anti-tissue transglutaminase (normal range below 20 U/ml),5duration of... -
Plasmids used in this study.
aLike YCpHA-BUD8 [20] except in a YEplac111 [53] background.bLike YEpGFP*-BUD8 [20] except with two in-frame copies of the GFP coding sequence and in a YCplac33 [53] background. -
Experimental groups.
Adult male and female mice used in this study were; Mc1re, recessive yellow mice, which are null mutants with a non-functional MC1R resulting in a yellow coat colour and their... -
Oligonucleotides used in this study.
aSequences in upper case letters are derived from the genome sequences of H. pylori 26695 [25], H. hepaticus[32], C. jejuni[33] and W. succinogenes[34]. Sequences introduced for... -
Strain_List
This table contains the strains used in our publication describing an inhibitory agent that inhibits the growth of strains containing pMPPla107. -
dedup_wf_001--87621acd46c5aab91ef3cbb037f951a7
Background Growing evidence suggests that second-generation cryoballoon ablation (2G-CB) is effective in patients with persistent atrial fibrillation (PerAF). The cornerstone... -
Clinicians' contributions to the development of coronary artery stents: a qua...
Background Medical device innovation remains poorly understood, and policymakers disagree over how to incentivize early development. We sought to elucidate the components of... -
iPad-Assisted Measurements of Duration Estimation in Psychiatric Patients and...
Handheld devices with touchscreen controls have become widespread in the general population. In this study, we examined the duration estimates (explicit timing) made by patients... -
How long do new medicines take to reach Canadian patients after companies fil...
Introduction Studies of the delay between when companies file a New Drug Submission (NDS) and when drugs reach Canadian patients typically focus on the time in the regulatory... -
Pharmacological characterization of potent and selective NaV1.7 inhibitors en...
Identification of voltage-gated sodium channel NaV1.7 inhibitors for chronic pain therapeutic development is an area of vigorous pursuit. In an effort to identify more potent... -
A typology of community and stakeholder engagement based on documented exampl...
Background Despite broad consensus on the importance of community and stakeholder engagement (CSE) for guiding the development, regulation, field testing, and deployment of... -
Light-induced gene expression with photocaged IPTG for induction profiling in...
Background Inducible expression systems are frequently used for the production of heterologous proteins. Achieving maximum product concentrations requires induction profiling,... -
Functional inclusion bodies produced in the yeast Pichia pastoris
Background Bacterial inclusion bodies (IBs) are non-toxic protein aggregates commonly produced in recombinant bacteria. They are formed by a mixture of highly stable...
